Top Markets
Coin of the day
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Rang in aandelen #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Aandeelprijs
$0.00023723
Laatst gesynchroniseerd: 2024-08-26
Marktkapitalisatie
$1.41K
Verandering (1 dag)
111.67%
Verandering (1 jaar)
0.00%
Land
FR
Handel Pharnext S.A. (ALPHA)

Categorie

Aandelsplitsingen voor Pharnext S.A. (ALPHA)
Het aandeel Pharnext S.A. (symbool: ALPHA) heeft in totaal 4 splitsingen ondergaan.
De meest recente splitsing vond plaats op Feb 15, 2024.
Eén aandeel ALPHA dat vóór Nov 23, 2022 werd gekocht, staat nu gelijk aan 4.0E-16 aandelen ALPHA.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
2024-02-15 1:10000 x0.0001 x4.0E-16
2023-09-18 1:5000 x0.0002 x4.0E-12
2023-05-10 1:10000 x0.0001 x2.0E-8
2022-11-23 1:5000 x0.0002 x0.0002
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR